# Inhibition of the angiotensin-converting enzyme N-terminal catalytic domain prevents endogenous opioid degradation in brain tissue

**Authors:** Filip Hanak, Jessica L. Swanson, Krzysztof Felczak, Prakashkumar Dobariya, Ursula C.H. Girdwood, Kenneth E. Bernstein, Swati S. More, Patrick E. Rothwell

PMC · DOI: 10.1172/jci.insight.194624 · JCI Insight · 2025-11-18

## TL;DR

Blocking a specific enzyme domain increases natural opioid signals in the brain.

## Contribution

A new method to enhance endogenous opioids by inhibiting a specific enzyme domain is introduced.

## Key findings

- Blocking the N-terminal domain of angiotensin-converting enzyme increases Met-enkephalin-Arg-Phe signals.
- This inhibition prevents degradation of endogenous opioids in brain tissue.

## Abstract

Natural opioid signals in the brain produced by Met-enkephalin-Arg-Phe are enhanced after blocking its degradation by the N-terminal catalytic domain of angiotensin-converting enzyme.

## Full-text entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12890470/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12890470/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12890470/full.md

---
Source: https://tomesphere.com/paper/PMC12890470